SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 117 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,903,031 | -33.4% | 957,509 | -4.0% | 1.62% | -30.7% |
| Q2 2023 | $20,879,684 | +15.8% | 997,596 | +16.8% | 2.35% | -14.6% |
| Q1 2023 | $18,034,030 | +102828.1% | 853,884 | +24.0% | 2.75% | +4.0% |
| Q4 2022 | $17,521 | -99.9% | 688,445 | -6.7% | 2.64% | -7.4% |
| Q3 2022 | $17,737,000 | +235.4% | 738,110 | +212.1% | 2.85% | +35.4% |
| Q1 2021 | $5,288,000 | -28.0% | 236,500 | -28.4% | 2.11% | -47.2% |
| Q4 2020 | $7,346,000 | – | 330,315 | – | 3.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,932,800 | $33,592,000 | 10.90% |
| Aisling Capital Management LP | 1,025,000 | $17,815,000 | 9.61% |
| Frazier Life Sciences Management, L.P. | 3,195,403 | $55,536,000 | 4.73% |
| Paradigm Biocapital Advisors LP | 701,356 | $12,190,000 | 3.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,277,413 | $22,201,000 | 3.14% |
| Nantahala Capital Management | 2,692,303 | $46,792,000 | 2.07% |
| Avidity Partners Management LP | 4,823,400 | $83,831,000 | 1.75% |
| DAFNA Capital Management LLC | 371,987 | $6,465,000 | 1.68% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $3,582,000 | 1.67% |
| BVF INC/IL | 2,394,714 | $41,620,000 | 1.66% |